2023 年3 期 第31 卷
病例研究![HTML下载 HTML下载](/Areas/201911120101/Content/img/icon_html.png)
![PDF下载 PDF下载](/Areas/201911120101/Content/img/icon_pdf.png)
地尔硫卓救治血管痉挛性心绞痛合并Ⅲ度房室传导阻滞一例报道
DiltiazemintheTreatmentofVasospasticAnginaComplicatedwithDegreeⅢ AtrioventricularBlock:aCaseReport
作者:张瑾,刘成伟,韩敏,何亚峰
- 单位:
- 1.武汉科技大学医学院2.武汉科技大学附属武汉亚洲心脏病医院心内科3.武汉科技大学附属武汉亚洲心脏病医院超声科
- Units:
- 1.MedicalCollegeofWuhanUniversityofScienceandTechnology,Wuhan430065,China2.DepartmentofCardiology,WuhanAsiaHeartHospitalAffiliatedtoWuhanUniversityofScienceandTechnology,Wuhan430022,China3.DepartmentofUltrasound,WuhanAsiaHeartHospitalAffiliatedtoWuhanUniversityofScienceandTechnology,Wuhan430022,China
- 关键词:
- 心绞痛; 血管痉挛性心绞痛; 房室传导阻滞; 地尔硫卓; 病例报告;
- Keywords:
- Anginapectoris;Vasospasticangina;Atrioventricularblock;Diltiazem;Casereports
- CLC:
- R541.4
- DOI:
- 10.12114/j.issn.1008-5971.2023.00.035
- Funds:
- 武汉市卫生健康委员会医学科研项目青年重点项目(WX19Q13)
摘要:
血管痉挛性心绞痛(VSA)是由冠状动脉可逆性痉挛导致的一种心肌缺血表现,室性心动过速、心室颤动和Ⅲ度房室传导阻滞(AVB)等致命性心律失常是该病最严重的并发症,其中Ⅲ度AVB约占1.47%,较少见。本文报道1例VSA合并Ⅲ度AVB患者,在排除阻塞性冠状动脉疾病后应用地尔硫■静脉推注,患者症状缓解,之后长期口服地尔硫■,心绞痛未再发作。
Abstract:
Vasospasticangina(VSA)isamanifestationofmyocardialischemiacausedbyreversiblespasmofcoronaryartery,andfatalarrhythmiassuchasventriculartachycardia,ventricularfibrillationanddegreeⅢatrioventricularblock(AVB)arethemostseriouscomplicationsofthedisease,ofwhichdegreeⅢAVBaccountsforabout1.47%,whichisrare.ThispaperreportsacaseofVSAcombinedwithdegreeⅢAVB.Afterexcludingobstructivecoronaryarterydisease,diltiazemwasintravenouslyinjected,andthepatient'ssymptomswererelieved,andthenlong-termoraldiltiazemwasconducted,andanginapectorisdidnotrecur.
ReferenceList: